Penumbra Inc (PEN) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $342.07
• Market Cap: $13.29B
• P/E Ratio: 80.64
• EPS: $4.20
• 52-Week High: $362.41
• 52-Week Low: $221.26

Market Sentiment

Penumbra Inc currently has a Bullish sentiment score of 0.41.

About Penumbra Inc

Penumbra, Inc. is a biotechnology-driven medical device company focused on transforming the treatment landscape for neurological and vascular conditions. Based in Alameda, California, Penumbra employs a global reach with operations across major markets, including the United States, Europe, Canada, and Australia. The company's dedication to innovation and quality underpins its portfolio of advanced therapeutic solutions, aimed at improving patient outcomes and enhancing clinician workflows, th...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Penumbra Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PEN pay dividends?

Penumbra Inc (PEN) does not currently pay a regular dividend.

What is PEN's P/E ratio?

Penumbra Inc has a price-to-earnings (P/E) ratio of 80.64.

What is PEN's market cap?

Penumbra Inc (PEN) has a market capitalization of $13.29B with a current stock price of $342.07.